Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
5395.45
Change Change %
-85.40 -1.56%

Updated:24 May, 2019, 15:56 PM IST

BSE
5396.00
Change Change %
-97.50 -1.77%

Updated:24 May, 2019, 16:01 PM IST

Sanofi India  previously known as Aventis Pharma (APL) was incorporated on May 1956 as Hoechst Fedco Pharma. Later the name was changed to Hoechst Pharmaceuticals, Hoechst India and Hoechst Marion Roussel.

Sanofi–aventis is one of the world's leading pharmaceutical companies, and its 100% subsidiary, Hoechst GmbH together hold 50.12 percent of its paid–up share capital.In India, Sanofi operates through five entities ? Sanofi India Limited (previously known as Aventis Pharma Limited), Sanofi–Synthelabo (India) Limited, Sanofi Pasteur India Private Limited, Shantha Biotechnics Limited and Genzyme India Private Limited.

The company develops medicines in therapeutic areas such as cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, disorders of the central nervous system, internal medicine and vaccines. 

The company’s product portfolio consists of leading brands like Clexane, Cardace, Daonil, Lantus, Taxotere, Soframycin,  

Combiflam, Arava, Lasix and many more.

The manufacturing facilities are located at Ankleshwar (Gujarat) and Goa.

Company’s Ankleshwar unit has received ISO 14001 for Environment Management System.

The company exports to countries like Russia, Sri Lanka, U.K and Egypt amongst others.

Business area

Backed by a world–class R&D pipeline, Sanofi India has leading positions in the following major therapeutic areas:

Cardiovascular Diseases
Thrombosis
Diabetes
Internal Medicine
Central Nervous System
Oncology
Arthritis and Osteoporosis
Primary Health Care
Vaccines
Consumer Healthcare

Top